BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)

SHA:688166 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 29, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	25,260	12,748	14,786	9,535	15,051	18,778
Market Cap Growth	138.51%	-13.79%	55.07%	-36.65%	-19.85%	44.16%
Enterprise Value	26,935	14,391	15,983	10,606	15,560	18,464
Last Close Price	59.80	30.15	34.85	22.36	36.17	45.02
PE Ratio	252.60	67.39	73.03	39.79	61.70	110.54
Forward PE	96.45	28.00	28.00	28.00	43.06	52.05
PS Ratio	21.73	9.94	12.54	9.37	14.30	23.91
PB Ratio	9.77	5.23	6.12	4.25	8.64	13.11
P/TBV Ratio	10.59	5.54	6.52	4.54	9.47	13.58
P/OCF Ratio	121.47	51.91	75.92	30.63	85.48	120.81
EV/Sales Ratio	23.17	11.22	13.55	10.43	14.79	23.51
EV/EBITDA Ratio	116.91	48.52	58.11	39.13	54.92	86.56
EV/EBIT Ratio	287.85	71.68	76.75	45.84	62.45	100.84
Debt / Equity Ratio	0.89	0.92	0.91	0.90	0.52	0.15
Debt / EBITDA Ratio	10.00	7.20	7.71	7.17	3.10	1.03
Asset Turnover	0.22	0.25	0.24	0.27	0.44	0.48
Inventory Turnover	1.54	1.58	1.74	1.63	2.33	2.14
Quick Ratio	0.89	1.06	1.49	1.92	1.23	2.39
Current Ratio	1.33	1.56	2.00	2.39	1.70	3.24
Return on Equity (ROE)	2.43%	5.82%	7.44%	10.62%	14.97%	12.34%
Return on Assets (ROA)	1.10%	2.46%	2.69%	3.79%	6.49%	7.04%
Return on Capital (ROIC)	1.21%	2.70%	2.93%	4.19%	7.25%	7.72%
Return on Capital Employed (ROCE)	2.20%	4.90%	5.10%	6.00%	10.40%	11.90%
Earnings Yield	0.40%	1.48%	1.37%	2.51%	1.62%	0.91%
FCF Yield	-0.73%	-0.09%	-1.41%	-4.36%	-4.87%	-1.06%
Dividend Yield	0.16%	0.32%	0.27%	0.51%	0.33%	0.19%
Payout Ratio	172.16%	71.75%	56.80%	41.77%	22.26%	20.84%
Buyback Yield / Dilution	0.42%	0.34%	-2.10%	-1.61%	1.87%	-11.90%
Total Shareholder Return	0.58%	0.66%	-1.82%	-1.10%	2.21%	-11.71%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.